Market Indices
Latest News
 |
Goldman Sachs analyst issues NEUTRAL recommendation for NWG on December...
December 3, 2025 NWG -1.39% |
| ||
| ||
| ||
|
Price Targets
from Guggenheim issued a price target of $35.00 for DBVT on 2025-12-03 11:12:34.The adjusted price target was set to $35.00.At the time of the announcement, DBVT was...
December 3, 2025 DBVT 1.05%
from Maxim Group issued a price target of $200.00 for BLTE on 2025-12-02 20:05:14.The adjusted price target was set to $200.00.At the time of the announcement, BLTE...
December 2, 2025 BLTE 1.00%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| KZIA Kazia Therapeutics Limite | 13.19
31.11% | ||||||||||||||||||
| IXHL Incannex Healthcare Limit | 0.46
16.49% | ||||||||||||||||||
| STKH Steakholder Foods Ltd. | 3.06
13.75% | ||||||||||||||||||
| MREO Mereo BioPharma Group plc | 1.96
12.00% | ||||||||||||||||||
| AUTL Autolus Therapeutics plc | 1.48
10.07% | ||||||||||||||||||
| ADXN Addex Therapeutics Ltd | 8.86
10.06% | ||||||||||||||||||
| SUPV Grupo Supervielle S.A. | 11.74
7.51% | ||||||||||||||||||
| CEPU Central Puerto S.A. | 17.79
7.49% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 6.61%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA 3.68%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 CUK 0.61%